Here is the list of my papers that were published in 2024. Manuscripts were published in Value in Health, BMJ Open, Journal of Comparative Effectiveness Research, Forum for Health Economics and Policy, Annals of the American Thoracic Society and others. Links to all papers are below.
- Clayton D, Shafrin J, Yen GP, Geevarghese L, Shi Y, Waheed A. A Retrospective Claims Analysis of the Rate of Complications in Patients Undergoing Treatment for Paroxysmal Nocturnal Hemoglobinuria. Advances in Therapy. 2024 Nov 5:1-0.
- Clayton D, Shafrin J, Yen G, Lee S, Geevarghese L, Shi Y, He L, Shen Y, Waheed A. Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis. Clinical and Applied Thrombosis/Hemostasis. 2024 Jan;30:10760296231213073.
- Fischer R, Furlong P, Kennedy A, Maynard K, Penrod M, Miller D, Laverty CG, Lowes LP, Kuntz NL, Shieh PB, Kondejewski J, Neumann PJ, Shafrin J, Willke RJ. Healthcare Stakeholder Perspectives on a Value Assessment Approach for Duchenne Muscular Dystrophy Therapies. Journal of Multidisciplinary Healthcare. 2024 Aug 29;17:4199.
- Kim J, Nighohossian J, Daifotis AG, He J, Shafrin J. Impact of Delayed Adoption of Novel Atrial Fibrillation Treatments. The American Journal of Managed Care. December 2024. 30(12): 674-680.
- Kim J, Wang S, Sikirica S, Shafrin J. Cost–effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failure. Journal of Comparative Effectiveness Research. 2024 Jun;13(6):e230190.
- Ost DE, Maldonado F, Shafrin J, Kim J, Marin MA, Amos TB, Hertz DS, Kalsekar I, Vachani A. Economic value of bronchoscopy technologies that improves sensitivity for malignancy for peripheral pulmonary lesions. Annals of the American Thoracic Society. 2024 Dec;21(12):1759-69.
- Shafrin J, Kim J, Cohen JT, Garrison LP, Goldman DA, Doshi JA, Krieger J, Lakdawalla DN, Neumann PJ, Phelps CE, Whittington MD. Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices. Forum for Health Economics and Policy 2024 Nov 13 (Vol. 27, No. 1, pp. 29-116). De Gruyter.
- Shafrin, J., Kim, J., Marin, M., Ramsagar, S., Davies, M.L., Stewart, K., Kalsekar, I. and Vachani, A., 2024. Quantifying the Value of Reduced Health Disparities: Low-Dose Computed Tomography Lung Cancer Screening of High-Risk Individuals Within the United States. Value in Health, 27(3), pp.313-321.
- Shafrin J, Wang S, Sharma K, Spurrier K, Nordyke RJ. Will the Institute for Clinical and Economic Review’s Shared Savings Approach Decrease Value-Based Prices Most for the Most Severe Diseases? Value in Health. 2024 Sep 30.
- Wang S, Shafrin J, Kerr KW, Schuetz P. Health economic value of postacute oral nutritional supplementation in older adult medical patients at risk for malnutrition: a US-based modelling approach. BMJ Open. 2024 Nov 1;14(11):e086787.
Not included are a large number of conference posters/presentations and conference panels.